Bulletin of the Korean Chemical Society

Korean Chemical Society (대한화학회)
권호 표지
DOI QR코드

DOI QR Code

Synthesis and Pharmacological Studies for New Benzotriazole and Dibenzodiazepine Derivatives as Antipsychotic Agents

  • El-Sabbagh, Osama I. (Department of Medicinal Chemistry, Faculty of Pharmacy, Zagazig University) ;
  • El-Nabtity, Sameh M. (†Department of Pharmacology, Faculty of Veterinary Medicine, Zagazig University)
  • Published : 2009.07.20
Download PDF
⟨ Previous Next ⟩

Abstract

New benzotriazoles (5-8) or dibenzodiazepine derivatives (11-18) were synthesized starting from 3-[(2-amino- 4,5-disubstitutedphenyl)amino]-5,5-disubstitutedcyclohex-2-enones (1-4) through internal coupling of their diazonium salts or internal Mannich reaction in the presence of aromatic aldehydes. Pharmacological evaluation of benzotriazole and dibenzodiazepine derivatives for their clozapine-like properties revealed that dibenzodiazepine 11 bearing 4-bromophenyl group exhibited the same antipsychotic activity as the reference drug clozapine while the activity of benzotriazole 7 was 25% lesser than that of clozapine. Moreover, compounds 7 and 11 did not show significant CNS depressant activity as well as no or slight neurotoxicity on contrast to clozapine when tested in mice using forced swim, rotarod and horizontal screen tests.

Keywords

References

  1. Amitai, N.; Semenova, S.; Markou, A. Eur. J. Pharmacol. 2009, 602, 78 https://doi.org/10.1016/j.ejphar.2008.11.001
  2. McEvoy, J. P. J. Clin. Psychiatry 2007, 68 (Suppl. 14), 4 https://doi.org/10.4088/JCP.0207e04
  3. Maehara, S.; Hikichi, H.; Satow, A.; Okuda, S.; Ohta, H. Pharmacol. Biochem. Behav. 2008, 91, 140 https://doi.org/10.1016/j.pbb.2008.06.023
  4. Wiesel, F. A. Br. J. Psychiat. 1994, 164, 65
  5. Tomic, M.; Kundakovic, M.; Butorović, B.; Janac, B.; Andric, D.; Roglic, G.; Ignjatovic, D.; Kostić-Rajacic, S. Bioorg. Med. Chem. Lett. 2004, 14, 4263 https://doi.org/10.1016/j.bmcl.2004.06.005
  6. Caliendo, G.; Greco, G.; Grieco, P.; Novellino, E.; Perissuttil, E.; Santagada, V.; Barbarulo, D.; Esposito, E.; DeBlasi, A. Eur. J. Med. Chem. 1996, 31, 207 https://doi.org/10.1016/0223-5234(96)89136-7
  7. Liegeois, J. F. F.; Bruhwyler, J.; Rogister, F. A.; Delarge, J. E. Curr. Med. Chem. 1995, 1, 471
  8. Liegeois, J. F. F.; Bruhwyler, J.; Damas, J.; Nguyen, T. P.; Chleide, E. M. G.; Mercier, M. G. A.; Rogister, F. A.; Delarge, J. E. J. Med. Chem. 1993, 36, 2107 https://doi.org/10.1021/jm00067a009
  9. Meltzer, H. Y.; Li, Z.; Kaneda, Y.; Ichikawa, J. Prog. Neuropsycho. Pharmacol. 2003, 27, 1159
  10. Ichikawa, J.; Ishii, H.; Bonaccorso, S.; Fowler, W. L.; O'Laughlin, I. A.; Meltzer, H. Y. J. Neurochem. 2001, 76, 1521 https://doi.org/10.1046/j.1471-4159.2001.00154.x
  11. Bantick, R. A.; Deakin, J. F.; Grasby, P. M. J. Psychopharmacol. 2001, 15, 37 https://doi.org/10.1177/026988110101500108
  12. Burris, K. D.; Molski, T. F.; Xu, C.; Ryan, E.; Tottori, K.; Kikuchi, T.; Yocca, F. D.; Molinoff, P. B. J. Pharmacol. Exp. Ther. 2002, 302, 381 https://doi.org/10.1124/jpet.102.033175
  13. El-Sabbagh, O. I.; Abd-El Alim, A. F. Zag. J. Pharm. Sci. 2000, 9, 9
  14. Tonkikh, N. N.; Strakovs, A.; Rizhanova, K. V.; Petrova, M. V. Chem. Heterocycl. Comp. 2004, 40, 949 https://doi.org/10.1023/B:COHC.0000044581.23486.59
  15. Kametani, T.; Ihara, M.; Takahashi, K. Chem. Pharm. Bull. 1972, 20, 1588 https://doi.org/10.1248/cpb.20.1588
  16. Chen, G.; Bohner, B. Cited in Screening Methods in Pharmacology, 1st Ed.; Academic Press: New York and London, 1965; p 182
  17. Porsolt, R. D.; Anton, G.; Blanet, N.; Jalfre, M. Eur. J. Pharmacol. 1978, 47, 379 https://doi.org/10.1016/0014-2999(78)90118-8
  18. Dunham, N. W.; Miya, T. S. J. Am. Pharm. Assoc. Sci. Ed. 1957, 46, 208 https://doi.org/10.1002/jps.3030460322
  19. Coughenour, L. L.; Mclean, J. R.; Parker, R. B. Pharmacol. Biochem. Behav. 1977, 6, 351 https://doi.org/10.1016/0091-3057(77)90036-3
  20. Fisher, R. S. Brain Res. Rev. 1989, 14, 245 https://doi.org/10.1016/0165-0173(89)90003-9
  21. Osonoe, K.; Mori, N.; Suzuki, K.; Osonoe, M. Brain Res. 1994, 663, 338 https://doi.org/10.1016/0006-8993(94)91283-1
  22. Greenhill, J. V. J. Chem. Soc. Perkin I 1976, 2207
  23. Greenhill, J. V. Chem. Soc. Rev. 1977, 6, 277 https://doi.org/10.1039/cs9770600277
  24. Wiley, J. L. Euro. J. Pharmacol. 2008, 578, 216 https://doi.org/10.1016/j.ejphar.2007.09.010
  25. Mao, Q.-Q.; Ip, S.-P.; Tsai, S.-H.; Che, C.-T. J. Ethnopharmacology 2008, 119, 272 https://doi.org/10.1016/j.jep.2008.07.008
  26. Froimowitz, M.; Ramsby, S. J. Med. Chem. 1991, 34, 1707 https://doi.org/10.1021/jm00109a026
  27. Liegeois, J. F. F.; Rogister, F. A.; Bruhwyler, J.; Damas, J.; Nguyen, T. P.; Inarejos, M. O.; Chleide, E. M. G.; Meroier, M. G. A.; Delarge, J. E. J. Med. Chem. 1994, 37, 519 https://doi.org/10.1021/jm00030a011

Cited by

  1. Facile Synthesis of Benzotriazole Derivatives Using Nanoparticles of Organosilane-Based Nitrite Ionic Liquid Immobilized on Silica and Two Room-Temperature Nitrite Ionic Liquids vol.43, pp.20, 2013, https://doi.org/10.1080/00397911.2012.744840
  2. : a novel catalyst for the multicomponent synthesis of dibenzodiazepines under solvent-free conditions vol.5, pp.91, 2015, https://doi.org/10.1039/C5RA12085C
  3. Facile three-component preparation of benzodiazepine derivatives catalyzed by zinc sulfide nanoparticles via grinding method vol.42, pp.5, 2016, https://doi.org/10.1007/s11164-015-2254-4
  4. -proline as an organocatalyst and under catalyst-free conditions, and their evaluation as α-glucosidase inhibitors vol.41, pp.17, 2017, https://doi.org/10.1039/C7NJ01021D
  5. Metal-Catalyzed Routes to Dibenzodiazepines (DBDAs) and Structural Analogues: Recent Advances pp.1434193X, 2018, https://doi.org/10.1002/ejoc.201801304
  6. ChemInform Abstract: Synthesis and Pharmacological Studies for New Benzotriazole and Dibenzodiazepine Derivatives as Antipsychotic Agents. vol.40, pp.50, 2009, https://doi.org/10.1002/chin.200950186
  7. Palladium-catalysed regioselective N-arylation of anthranilamides: a tandem route for dibenzodiazepinone synthesis vol.43, pp.19, 2009, https://doi.org/10.1039/c9nj00539k
  8. Synthesis and characterization of CoFe2O4@SiO2@NH-NH2-PCuW as an acidic nano catalyst for the synthesis of 1,4-benzodiazepines and a powerful dye remover vol.166, pp.None, 2009, https://doi.org/10.1016/j.poly.2019.03.046
  9. New pyrazolyl-dibenzo[b,e][1,4]diazepinones: room temperature one-pot synthesis and biological evaluation vol.24, pp.2, 2009, https://doi.org/10.1007/s11030-019-09958-z